
<http://bio2rdf.org/drugbank:DB00123> a <http://schema.org/Drug> ;
	<http://schema.org/name> "L-Lysine" ;
	<http://schema.org/description> """L-Lysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. Its codons are AAA and AAG.

L-Lysine is a base, as are arginine and histidine. The ε-amino group often participates in hydrogen bonding and as a general base in catalysis. Common posttranslational modifications include methylation of the ε-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications include acetylation. Collagen contains hydroxylysine which is derived from lysine by lysyl hydroxylase. O-Glycosylation of lysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell.""" ;
	<http://schema.org/drugClass> "Amino Acids, Essential" , "Supplements" , "Micronutrients" , "Dietary Supplements" ;
	<http://schema.org/url> "http://bio2rdf.org/drugbank:DB00123" ;
	<http://schema.org/clinicalPharmacology> "Insures the adequate absorption of calcium; helps form collagen ( which makes up bone cartilage &amp; connective tissues); aids in the production of antibodies, hormones &amp; enzymes. Recent studies have shown that Lysine may be effective against herpes by improving the balance of nutrients that reduce viral growth. A deficiency may result in tiredness, inability to concentrate, irritability, bloodshot eyes, retarded growth, hair loss, anemia &amp; reproductive problems." ;
	<http://schema.org/cost> <http://bio2rdf.org/drugbank_resource:ac10ee9ca217c9b2c81191f32e120602> , <http://bio2rdf.org/drugbank_resource:85befe9d0b1e5913428d24834dfff6bd> , <http://bio2rdf.org/drugbank_resource:4ef3c9b2c778bb2cdad1caf487910579> , <http://bio2rdf.org/drugbank_resource:71f79dacb1cbe65005c7fc7e44942d33> , <http://bio2rdf.org/drugbank_resource:a2e7ed0e7b89aa77f2f4d91dadde35bd> , <http://bio2rdf.org/drugbank_resource:a62233461d8b565d6b3aee3234adc828> , <http://bio2rdf.org/drugbank_resource:a6deac13209ecaf808a90fb625814d3a> , <http://bio2rdf.org/drugbank_resource:33877ac1fc01dc57807399bfb7dc31a1> , <http://bio2rdf.org/drugbank_resource:d90e1f7c66b4de56346a2292f72e6b97> , <http://bio2rdf.org/drugbank_resource:b72cbfdf814d5922e23298ffd1b367bb> ;
	<http://schema.org/legalStatus> "Nutraceutical" , "Approved" ;
	<http://schema.org/mechanismOfAction> "Proteins of the herpes simplex virus are rich in L-arginine, and tissue culture studies indicate an enhancing effect on viral replication when the amino acid ratio of L-arginine to L-lysine is high in the tissue culture media. When the ratio of L-lysine to L-arginine is high, viral replication and the cytopathogenicity of herpes simplex virus have been found to be inhibited. L-lysine may facilitate the absorption of calcium from the small intestine." ;
	<http://schema.org/nonProprietaryName> "lysine acid" , "LYS" , "6-ammonio-L-norleucine" , "(S)-lysine" , "(S)-2,6-diaminohexanoic acid" , "L-lys" , "(S)-α,ε-diaminocaproic acid" ;
	<http://schema.org/identifier> "drugbank:DB00123" ;
	<http://schema.org/sameAs> <http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lly_0166.shtml> , <http://www.drugbank.ca/drugs/DB00123> .

<http://bio2rdf.org/drugbank_resource:33877ac1fc01dc57807399bfb7dc31a1> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "63.240001678466796875" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Cayston 75 mg inhal solution" .

<http://bio2rdf.org/drugbank_resource:4ef3c9b2c778bb2cdad1caf487910579> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.15999999642372131348" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Lysine hcl powder" .

<http://bio2rdf.org/drugbank_resource:71f79dacb1cbe65005c7fc7e44942d33> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.070000000298023223877" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "L-lysine hcl 500 mg tablet" .

<http://bio2rdf.org/drugbank_resource:85befe9d0b1e5913428d24834dfff6bd> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.039999999105930328369" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "L-lysine 1000 mg tablet" .

<http://bio2rdf.org/drugbank_resource:a2e7ed0e7b89aa77f2f4d91dadde35bd> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.019999999552965164185" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Lysine 500 mg tablet" .

<http://bio2rdf.org/drugbank_resource:a62233461d8b565d6b3aee3234adc828> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.079999998211860656738" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Ra l-lysine 1000 mg tablet" .

<http://bio2rdf.org/drugbank_resource:a6deac13209ecaf808a90fb625814d3a> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.15999999642372131348" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "L-lysine ointment" .

<http://bio2rdf.org/drugbank_resource:ac10ee9ca217c9b2c81191f32e120602> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.029999999329447746277" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "CVS Pharmacy l-lysine 500 mg tablet" .

<http://bio2rdf.org/drugbank_resource:b72cbfdf814d5922e23298ffd1b367bb> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.039999999105930328369" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "L-lysine 500 mg tablet" .

<http://bio2rdf.org/drugbank_resource:d90e1f7c66b4de56346a2292f72e6b97> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "304.5" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Neoprofen 20 mg/2 ml vial" .
